G. Ricaurte

发表

Drug abuse and dependence: hazards and consequences of heroin, cocaine and amphetamines

U. McCann, G. Ricaurte, U. Mccann, 2000 .

Kinetic Analysis of [11C]McN5652: A Serotonin Transporter Radioligand

M. Kraut, Z. Szabo, R. Dannals, 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428

D. Wong, U. McCann, R. Dannals, 1998, The Journal of Neuroscience.

In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428

D. Wong, M. Kuhar, R. Dannals, 1993, Synapse.

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

J. Krystal, L. Price, G. Heninger, 1992, The American journal of drug and alcohol abuse.

Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine

L. Seiden, K. Perry, G. Ricaurte, 1983, Neuropharmacology.

Amphetamine: effects on catecholamine systems and behavior.

L S Seiden, L. Seiden, G. Ricaurte, 1993, Annual review of pharmacology and toxicology.

Identifying the serotonin transporter signal in Western blot studies of the neurotoxic potential of MDMA and related drugs

U. McCann, G. Ricaurte, Michael Mclane, 2011, Synapse.

Heating induces aggregation and decreases detection of serotonin transporter protein on western blots

U. McCann, G. Ricaurte, Michael Mclane, 2007, Synapse.

Assessing long-term effects of MDMA (Ecstasy)

U. McCann, G. Ricaurte, 2001, The Lancet.

Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine

L. Seiden, G. Ricaurte, C. Schuster, 1983, Neuropharmacology.

Amphetamine Treatment Similar to That Used in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder Damages Dopaminergic Nerve Endings in the Striatum of Adult Nonhuman Primates

U. McCann, G. Ricaurte, A. H. Mayne, 2005, Journal of Pharmacology and Experimental Therapeutics.

Inhibition of 3,4‐methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4‐dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: Implications for mechanisms of neurotoxicity

U. McCann, G. Ricaurte, Melanie Mueller, 2011, Synapse.

Synthesis and neurotoxicity profile of 2,4,5-trihydroxymethamphetamine and its 6-(N-acetylcystein-S-yl) conjugate.

U. McCann, G. Ricaurte, Melanie Mueller, 2011, Chemical research in toxicology.

Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity

U. McCann, G. Ricaurte, F. Peters, 2009, Drug Metabolism and Disposition.

Further Studies on the Role of Metabolites in MDMA-induced Serotonergic Neurotoxicity

U. McCann, G. Ricaurte, F. Peters, 2009 .

Altered prolactin response to M‐chlorophenylpiperazine in monkeys previously treated with 3,4‐methylenedioxymethamphetamine (MDMA) or fenfluramine

U. McCann, G. Ricaurte, G. Hatzidimitriou, 2002, Synapse.

Long‐term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine

G. Ricaurte, B. Cord, B. Callahan, 2001, Synapse.

Adverse Reactions with 3,4-Methylenedioxymethamphetamine (MDMA; ‘Ecstasy’)

U. McCann, G. Ricaurte, S. O. Slate, 1996, Drug safety.

Neurotoxic Amphetamine Analogues: Effects in Monkeys and Implications for Humans a

U. McCann, G. Ricaurte, U. Mccann, 1992, Annals of the New York Academy of Sciences.

Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl] propane [(methylenedioxy)methamphetamine].

G. Ricaurte, N. Castagnoli, T. Steele, 1992, Chemical research in toxicology.

Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA)

G. Ricaurte, J. Katz, T. Steele, 1992, Brain Research.

Neuropathology of cocaine abuse

U. McCann, G. Ricaurte, U. Mccann, 1999 .

Quantitative Positron Emission Tomography Studies of the Serotonin Transporter in Humans Previously Treated with the Appetite Suppressants Fenfluramine or Dexfenfluramine

Z. Szabo, U. McCann, R. Dannals, 2007, Molecular Imaging and Biology.

Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine

U. McCann, G. Ricaurte, Victoria Eligulashvili, 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma.

G. Ricaurte, F. Peters, H. Maurer, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Identification and Characterization of Metallothionein-1 and -2 Gene Expression in the Context of (±)3,4-Methylenedioxymethamphetamine-Induced Toxicity to Brain Dopaminergic Neurons

K. Becker, C. Cheadle, U. McCann, 2004, The Journal of Neuroscience.

Hepatitis C: bad news for substance misusers

G. Ricaurte, H. Ghodse, 2022 .

Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum

J. Langston, G. Ricaurte, I. Irwin, 1985, Neuroscience Letters.

Older dopaminergic neurons do not recover from the effects of MPTP

J. Langston, G. Ricaurte, I. Irwin, 1987, Neuropharmacology.

Dopamine is not essential for the development of methamphetamine-induced neurotoxicity

R. Palmiter, M. Darvas, U. McCann, 2010, Journal of neurochemistry.

Evidence against an essential role of endogenous brain dopamine in methamphetamine‐induced dopaminergic neurotoxicity

U. McCann, G. Ricaurte, Jie Yuan, 2001, Journal of neurochemistry.

Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity

U. McCann, G. Ricaurte, Jie Yuan, 2002, Journal of neurochemistry.

The sensitivity of nigrostriatal dopamine neurons to MPP+ does not increase with age

J. Langston, G. Ricaurte, I. Irwin, 1988, Neuroscience Letters.

Fenfluramine‐induced loss of serotonin transporters in baboon brain visualized with PET

Z. Szabo, R. Dannals, H. Ravert, 1996, Synapse.

Dexfenfluramine neurotoxicity in brains of non-human primates

M. Wilson, M. Molliver, G. Ricaurte, 1991, The Lancet.

Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.

U. McCann, G. Ricaurte, J. Katz, 1994, The Journal of pharmacology and experimental therapeutics.

Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.

U. McCann, G. Ricaurte, 1993, Journal of clinical psychopharmacology.

Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons

U. McCann, G. Ricaurte, R. Irvine, 2006, Neuropsychopharmacology.

Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Baboons after Oral Administration: Comparison with Humans Reveals Marked Differences

U. McCann, G. Ricaurte, Melanie Mueller, 2011, Journal of Pharmacology and Experimental Therapeutics.

Direct Comparison of (±) 3,4-Methylenedioxymethamphetamine (“Ecstasy”) Disposition and Metabolism in Squirrel Monkeys and Humans

U. McCann, M. Huestis, G. Ricaurte, 2009, Therapeutic drug monitoring.

Nonlinear Pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) and Its Major Metabolites in Squirrel Monkeys at Plasma Concentrations of MDMA That Develop After Typical Psychoactive Doses

U. McCann, G. Ricaurte, F. Peters, 2008, Journal of Pharmacology and Experimental Therapeutics.

Non-linear Pharmacokinetics of MDMA ( “ Ecstasy ” ) and its Major Metabolites in Squirrel Monkeys at Plasma Concentrations of MDMA that Develop After Typical Psychoactive Doses

U. McCann, G. Ricaurte, F. Peters, 2008 .

Methylphenidate and brain dopamine neurotoxicity

U. McCann, G. Ricaurte, Jie Yuan, 1997, Brain Research.

The effect of N-methylation on fenfluramine's neurotoxic and pharmacologic actions

G. Ricaurte, J. Katz, N. Castagnoli, 1997, Brain Research.

Pharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents

G. Ricaurte, J. Katz, Melanie Mueller, 2018, Behavioural pharmacology.

Effects of MDMA on blood glucose levels and brain glucose metabolism

M. Desco, C. Arango, J. Vaquero, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Cognitive Performance of MDMA-Treated Rhesus Monkeys: Sensitivity to Serotonergic Challenge

L. Parsons, L. Gold, G. Ricaurte, 2002, Neuropsychopharmacology.

Studies of (±)-3,4-Methylenedioxymethamphetamine (MDMA) Metabolism and Disposition in Rats and Mice: Relationship to Neuroprotection and Neurotoxicity Profile

U. McCann, G. Ricaurte, Melanie Mueller, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Microsoft Word-75965117-file00

G. Ricaurte, Melanie Mueller, Jie Yuan, 2012 .

Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.

G. Ricaurte, J. Katz, M. Martello, 1992, The Journal of pharmacology and experimental therapeutics.

Major metabolites of(±)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons

U. McCann, G. Ricaurte, U. Mccann, 1991, Brain Research.

5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates

J. Langston, G. Ricaurte, I. Irwin, 1988, Brain Research.

N-Methylation dissociates methamphetamine's neurotoxic and behavioral pharmacologic effects

G. Ricaurte, J. Katz, G. Hatzidimitriou, 1997, Brain Research.

Experimental studies on 3,4-methylenedioxymethamphetamine (MDMA, “ECSTASY”) and its potential to damage brain serotonin neurons

U. McCann, G. Ricaurte, U. Mccann, 2009, Neurotoxicity Research.

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies

U. McCann, G. Ricaurte, Victoria Eligulashvili, 2000, Neuropsychobiology.

Reinforcing effects of enantiomers of N,N-dimethylamphetamine in squirrel monkeys

J. Witkin, G. Ricaurte, J. Katz, 2005, Psychopharmacology.

Chapter 38 – Neuropsychiatric Complications of Substance Abuse

U. McCann, G. Ricaurte, J. Langston, 2008 .

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations a

J. Langston, G. Ricaurte, I. Irwin, 1990, Annals of the New York Academy of Sciences.

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.

J. Krystal, L. Price, G. Heninger, 1989, Archives of general psychiatry.

Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study

L. Seiden, G. Ricaurte, C. Schuster, 1980, Brain Research.

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

Z. Szabo, U. McCann, G. Ricaurte, 2000, Toxicology letters.

Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users.

U. McCann, G. Ricaurte, U. Mccann, 1991, Journal of clinical psychopharmacology.

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

J. Langston, G. Ricaurte, I. Irwin, 1988, Brain Research.

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

L. Seiden, G. Ricaurte, G. Bryan, 1985, Science.

Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study

U. McCann, G. Ricaurte, Victoria Eligulashvili, 1999, Psychopharmacology.

Long-term effects of chronic methamphetamine administration in rhesus monkeys

L. Seiden, L. Forno, G. Ricaurte, 1989, Brain Research.

Behavioral and Neurochemical Consequences of Long-Term Intravenous Self-Administration of MDMA and Its Enantiomers by Rhesus Monkeys

G. Ricaurte, J. Woods, M. Kilbourn, 2004, Neuropsychopharmacology.

Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep.

U. McCann, R. Allen, G. Ricaurte, 1993, Sleep.

Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma

M. Huestis, G. Ricaurte, F. Peters, 2009, Analytical and bioanalytical chemistry.

Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment

J. Langston, L. Forno, G. Ricaurte, 1986, Brain Research.

Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities.

C. Wihler, V. Coppola, L. Tessarollo, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Acute poisoning with amphetamines (MDEA) and heroin: Antagonistic effects between the two drugs

L. Bossaert, P. Jorens, P. Schepens, 1996, Intensive Care Medicine.

Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

Y. Shaham, U. McCann, G. Ricaurte, 1994, Neuropsychopharmacology.

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

L. Seiden, G. Ricaurte, Richard J. Miller, 1980, Brain Research.

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

James Robert Brašić, D. Wong, U. McCann, 2008, Synapse.

Effect of Temperature on Dopamine Transporter Function and Intracellular Accumulation of Methamphetamine: Implications for Methamphetamine-Induced Dopaminergic Neurotoxicity

U. McCann, G. Ricaurte, Saejeong J. Kim, 2000, The Journal of Neuroscience.

Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers

L. Seiden, G. Ricaurte, C. Schuster, 1984, Brain Research.

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

R. Guillery, L. Seiden, R. Moore, 1982, Brain Research.

Positron emission tomography of striatal serotonin transporters in Parkinson disease.

John Hilton, Dean F Wong, Zsolt Szabo, 2003, Archives of neurology.

Recognition and management of complications of new recreational drug use

U. McCann, G. Ricaurte, Una D McCann, 2005, The Lancet.

Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse.

G. Ricaurte, J. Katz, J. Tolliver, 1996, The Journal of pharmacology and experimental therapeutics.

Effect of Glucoprivation on Serotonin Neurotoxicity Induced by Substituted Amphetamines

U. McCann, G. Ricaurte, Jie Yuan, 2002, Journal of Pharmacology and Experimental Therapeutics.

Fenfluramine's appetite suppression and serotonin neurotoxicity are separable.

U. McCann, G. Ricaurte, J. Yuan, 1995, European journal of pharmacology.

Neurochemical similarities between d,l-cathinone and d-amphetamine.

L. Seiden, K. Preston, G. Ricaurte, 1982, Drug and alcohol dependence.

Nerve terminal degeneration after a single injection of D-amphetamine in iprindole-treated rats: relation to selective long-lasting dopamine depletion

R. Guillery, L. Seiden, G. Ricaurte, 1984, Brain Research.

Orally administered MDMA causes a long-term depletion of serotonin in rat brain

J. Langston, G. Ricaurte, S. Peroutka, 1988, Brain Research.

Effects of MDMA on the Human Nervous System

U. McCann, G. Ricaurte, U. Mccann, 2014 .

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals

U. McCann, G. Ricaurte, Jie Yuan, 2000, Neuropsychobiology.

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.

U. McCann, G. Ricaurte, T. Steele, 1994, Addiction.

Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")

U. McCann, G. Ricaurte, G. Hatzidimitriou, 2002, Science.

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

G. Ricaurte, J. Katz, C Fischer, 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat

G. Ricaurte, J. Katz, W. Dornan, 1991, Pharmacology Biochemistry and Behavior.

Behavioral Effects and Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons

G. Ricaurte, Melanie Mueller, A. Goodwin, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Sleep apnea in young abstinent recreational MDMA (“ecstasy”) consumers

U. McCann, G. Ricaurte, A. Schwartz, 2009, Neurology.

Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance

Z. Szabo, U. McCann, R. Dannals, 2008, Psychopharmacology.

Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms

U. McCann, G. Ricaurte, U. Mccann, 2007, TheScientificWorldJournal.

MDMA (“Ecstasy”) and panic disorder: Induction by a single dose

U. McCann, G. Ricaurte, U. Mccann, 1992, Biological Psychiatry.

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.

M. Wilson, J. Langston, L. Forno, 1988, JAMA.

3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain.

J. Langston, G. Ricaurte, I. Irwin, 1987, European journal of pharmacology.

Caveat Emptor: Editors Beware

U. McCann, G. Ricaurte, U. Mccann, 2001, Neuropsychopharmacology.

Memory impairment in abstinent MDMA ("Ecstasy") users

U. McCann, G. Ricaurte, K. Bolla, 1998, Neurology.

Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern Spain

J. Bobes, P. Sáiz, M. Bascarán, 2002, European Addiction Research.

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users

D. Murphy, U. McCann, G. Ricaurte, 1999, Psychopharmacology.

3,4-Methylenedioxymethamphetamine, serotonin and memory.

D. Olton, G. Wenk, G. Ricaurte, 1993, The Journal of pharmacology and experimental therapeutics.

Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans.

G. Ricaurte, 1989, NIDA research monograph.

"Ecstasy" and serotonin neurotoxicity: new findings raise more questions.

M. Molliver, U. McCann, G. Ricaurte, 2001, Archives of general psychiatry.

Amphetamine neurotoxicity: accomplishments and remaining challenges

U. McCann, G. Ricaurte, Una D McCann, 2004, Neuroscience & Biobehavioral Reviews.

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.

L. Seiden, U. McCann, G. Ricaurte, 1997, JAMA.

Chronic idiopathic ataxic neuropathy: neuropathology of a case

L. Forno, G. Ricaurte, L. Simon, 1989, Acta Neuropathologica.

Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine

L. Seiden, G. Ricaurte, C. Schuster, 2004, Psychopharmacology.

Changes in Gene Expression Linked to Methamphetamine-Induced Dopaminergic Neurotoxicity

K. Becker, T. Barrett, U. McCann, 2002, The Journal of Neuroscience.

Motor dynamics encoding in the rostral zone of the cat cerebellar flocculus during vertical optokinetic eye movements

U. McCann, G. Ricaurte, U. Mccann, 2000 .

REVIEW ■ : Long-lasting Effects of Recreational Drugs of Abuse on the Central Nervous System

U. McCann, G. Ricaurte, K. A. Lowe, 1997 .

Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine

M. Wilson, M. Molliver, G. Ricaurte, 1989, Neuroscience.

Neuroimaging of MDMA-Induced Neurotoxicity

Z. Szabo, U. McCann, G. Ricaurte, 2002 .

Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration

U. McCann, G. Ricaurte, J. M. Moerschbaecher, 2002, Psychopharmacology.

Dopamine transporter changes in neuropsychiatric disorders.

A. Gjedde, H. Singer, D. Wong, 1998, Advances in pharmacology.

Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys

J W Langston, J. Langston, L. Forno, 1986, Annals of neurology.

Sleep Deprivation Differentially Impairs Cognitive Performance in Abstinent Methylenedioxymethamphetamine (“Ecstasy”) Users

U. McCann, G. Ricaurte, F. Sgambati, 2009, The Journal of Neuroscience.

Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB

Zsolt Szabo, Z. Szabo, U. McCann, 2005, Neuropsychopharmacology.

Relationship between Temperature, Dopaminergic Neurotoxicity, and Plasma Drug Concentrations in Methamphetamine-Treated Squirrel Monkeys

U. McCann, G. Ricaurte, Melanie Mueller, 2006, Journal of Pharmacology and Experimental Therapeutics.

Recent advances in addiction research

G. Ricaurte, A. Ghodse, 2001 .

Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra

J. Langston, L. Forno, G. Ricaurte, 1987, Brain Research.

Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines

Jie Yuan, U. McCann, G. Ricaurte, 2006, Neuropsychopharmacology.

The amine-depleting effects of 5,7-dihydroxytryptamine (5,7-DHT) in C57BL/6 mice do not increase with age

J. Langston, G. Ricaurte, I. Irwin, 1989, Brain Research.

Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users

U. McCann, R. Edwards, G. Ricaurte, 2011, Psychopharmacology.

Neurotoxins, parkinsonism and Parkinson's disease.

J. Langston, G. Ricaurte, I. Irwin, 1987, Pharmacology & therapeutics.

The Effect of Catecholamine Depletion by Alpha-Methyl-Para-Tyrosine on Measures of Cognitive Performance and Sleep in Abstinent MDMA Users

U. McCann, G. Ricaurte, S. Peterson, 2007, Neuropsychopharmacology.

Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.

J L Katz, G. Ricaurte, C. Scanzello, 1993, The Journal of pharmacology and experimental therapeutics.

Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors

G. Ricaurte, U. Scheffel, J. Lever, 1992, Neuropharmacology.

Modulating role of dopamine on anesthetic requirements

M. Maze, J. Langston, G. Ricaurte, 1990 .

Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate

L. Seiden, G. Ricaurte, C. Schuster, 1980, Neurology.

Thalamic hemorrhage with neglect and memory disorder

S. Waxman, G. Ricaurte, Scott B. Tucker, 1986, Journal of the Neurological Sciences.

In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine‐123 labeled RTI‐55

H N Wagner, F I Carroll, D. Wong, 1992, Synapse.

Dexfenfluramine and neurotoxicity

M. Molliver, S. Garattini, B. Guy-grand, 1992, The Lancet.

Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug.

U. McCann, G. Ricaurte, G. Hatzidimitriou, 1997, The Journal of pharmacology and experimental therapeutics.

Fluoxetine increases the anorectic and long‐term dopamine‐depleting effects of phentermine

G. Ricaurte, Jie Yuan, B. Callahan, 2000, Synapse.

Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652

Zsolt Szabo, Stefano Marenco, S. Marenco, 1995, Synapse.

On the neurotoxicity of MDMA and related amphetamine derivatives.

G. Ricaurte, U. D. McConn, 1995, Journal of clinical psychopharmacology.

Subcortical aphasia revisited

M. Weinrich, S. Weinstein, G. Ricaurte, 1987 .

Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity.

G. Ricaurte, R. Westphalen, G. Hatzidimitriou, 2000, The Journal of pharmacology and experimental therapeutics.

A Murine Dopamine Neuron-Specific cDNA Library and Microarray: Increased COXI Expression during Methamphetamine Neurotoxicity

M. Ko, W. Wood, K. Becker, 2001, Neurobiology of Disease.

Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines

U. McCann, G. Ricaurte, G. Hatzidimitriou, 2008, Neuropsychopharmacology.

Comparison of (+)-11C-McN5652 and 11C-DASB as Serotonin Transporter Radioligands Under Various Experimental Conditions

John Hilton, Alan A. Wilson, Zsolt Szabo, 2002 .

Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.

John Hilton, Alan A. Wilson, Zsolt Szabo, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

J. Langston, G. Ricaurte, I. Irwin, 1987, The Journal of pharmacology and experimental therapeutics.

Acquisition of MDMA self‐administration: pharmacokinetic factors and MDMA‐induced serotonin release

G. Ricaurte, Melanie Mueller, S. Schenk, 2014, Addiction biology.

Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?

G. Ricaurte, U. Scheffel, Ursula Scheffel, 1990, Brain Research.

Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.

G. Ricaurte, Melanie Mueller, G. Hatzidimitriou, 2013, The international journal of neuropsychopharmacology.

Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasm

M. Huestis, G. Ricaurte, F. Peters, 2009, Forensic science international.

Retraction

G. Ricaurte, G. Hatzidimitriou, Jie Yuan, 2003, Science.

as Serotonin Transporter Radioligands Under Various Experimental Conditions

John Hilton, Alan A. Wilson, Zsolt Szabo, 2002 .

Assessment of serotonergic inervation with MCN5652/PET Validation of kinetic models in baboons

Z. Szabo, R. Dannals, H. Ravert, 1999 .

Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamine

J. Langston, J. Witkin, G. Ricaurte, 1989, Brain Research.

[123/125I]RTI‐55, an in vivo label for the serotonin transporter

M. Kuhar, R. Dannals, G. Ricaurte, 1992, Synapse.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.

J. Langston, G. Ricaurte, S. Peroutka, 1985, Research communications in chemical pathology and pharmacology.

The dopamine-depleting effect of 6-hydroxydopamine does not increase with aging

J. Langston, G. Ricaurte, I. Irwin, 1988, Brain Research.

Brain Dopamine Neurotoxicity in Baboons Treated with Doses of Methamphetamine Comparable to Those Recreationally Abused by Humans: Evidence from [11C]WIN-35,428 Positron Emission Tomography Studies and Direct In Vitro Determinations

D. Wong, R. Dannals, H. Ravert, 1998, The Journal of Neuroscience.

Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery

G. Ricaurte, G A Ricaurte, G Hatzidimitriou, 1999, The Journal of Neuroscience.

Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings

Z. Szabo, R. Dannals, G. Ricaurte, 1998, The Lancet.

Behavioral effects of N-methylamphetamine and N,N-dimethylamphetamine in rats and squirrel monkeys.

J. Witkin, G. Ricaurte, J. Katz, 1990, The Journal of pharmacology and experimental therapeutics.

Direction-dependent distortions of retinocentric space in the visuomotor transformation for pointing

G. Ricaurte, George A. Ricaurte, Hamid Ghodse, 2000 .

In vivo detection of short‐ and long‐term MDMA neurotoxicity—a positron emission tomography study in the living baboon brain

Z. Szabo, R. Dannals, H. Ravert, 1998, Synapse.

Positron Emission Tomography of 5-HT Transporter Sites in the Baboon Brain with [11C]McN5652

H N Wagner, M Suehiro, Z. Szabo, 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brain.

G. Ricaurte, F. Peters, H. Maurer, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats

R. Tallarida, G. Ricaurte, J. Katz, 2013, Psychopharmacology.

ULTRASTRUCTURE OF NERVE CELL DEGENERATION IN THE SUBSTANTIA NIGRA IN EXPERIMENTAL MPTP-INDUCED PARKINSONISM IN THE MOUSE AND IN THE SQUIRREL MONKEY

J. Langston, L. Forno, G. Ricaurte, 1986 .

Prolactin response to fenfluramine is independent of serotonin release.

G. Ricaurte, G. Hatzidimitriou, U. Mccann, 1996, European journal of pharmacology.

Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats

R. Tallarida, G. Ricaurte, J. Katz, 2013, Psychopharmacology.

PSYCHEDELIC DRUGS

G. Ricaurte, C. Nichols, D. Nichols, 2002 .

Inhibitors of Na+/H+ and Na+/Ca2+ exchange potentiate methamphetamine‐induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity

G. Ricaurte, Jie Yuan, B. Cord, 2001, Journal of neurochemistry.

Effect of 7‐nitroindazole on body temperature and methamphetamine‐induced dopamine toxicity

G. Ricaurte, B. Callahan, 1998, Neuroreport.

Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.

Alan A. Wilson, T. Owonikoko, Z. Szabo, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Validity of [123I]β‐CIT SPECT in detecting MDMA‐induced serotonergic neurotoxicity

Liesbeth Reneman, Jan Booij, G. D. den Heeten, 2002, Synapse.

Neurotoxic effects of (±)fenfluramine and phentermine, alone and in combination, on monoamine neurons in the mouse brain

G. Ricaurte, Jie Yuan, George A. Ricaurte, 1998, Synapse.

A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z.

H N Wagner, M Suehiro, R. Dannals, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.